Browse Category

Stocks News 5 December 2025 - 6 December 2025

Medical Properties Trust (MPW) Stock in December 2025: Dividend Hike, 50%+ Rebound and a High‑Risk 2026 Outlook

Medical Properties Trust (MPW) Stock in December 2025: Dividend Hike, 50%+ Rebound and a High‑Risk 2026 Outlook

Medical Properties Trust, Inc. (NYSE: MPW) has gone from market punchline to one of 2025’s most hotly debated turnaround stories in real estate. After a brutal drawdown driven by tenant bankruptcies and balance‑sheet worries, the healthcare REIT has staged a powerful rebound — but the recovery is still very much “under construction.” As of December 6, 2025, MPW trades around…
iRobot Stock (IRBT) Soars on Robotics Hype While Bankruptcy Risk Intensifies – Full Breakdown as of December 6, 2025

iRobot Stock (IRBT) Soars on Robotics Hype While Bankruptcy Risk Intensifies – Full Breakdown as of December 6, 2025

As of December 6, 2025, iRobot Corporation (NASDAQ: IRBT) – the Roomba maker that helped invent the home robot category – is back in the spotlight for all the wrong and all the exciting reasons at once. The stock has exploded higher on speculation that the White House will push a major federal initiative to support U.S. robotics, even as…
Vale S.A. Stock (VALE): Dam Provision Shock, Dividend Windfall and 2026 Outlook

Vale S.A. Stock (VALE): Dam Provision Shock, Dividend Windfall and 2026 Outlook

Updated: December 6, 2025 Where Vale stock stands after the December 5 sell‑off Vale S.A.’s New York–listed ADRs (NYSE: VALE) closed on Friday, December 5, around $12.90, down nearly 5% on the day after a sharp intraday reversal. Investing Even after that drop, the stock is still near a fresh 52‑week high around $13.4, set on December 4, and well…
EchoStar (SATS) Stock Soars on SpaceX Windfall and Spectrum Deals as Shares Hit Record High – December 6, 2025

EchoStar (SATS) Stock Soars on SpaceX Windfall and Spectrum Deals as Shares Hit Record High – December 6, 2025

Published: December 6, 2025 – For informational purposes only, not investment advice. EchoStar Stock Today: Record Highs After a Wild Week EchoStar Corporation (NASDAQ: SATS) has just delivered one of the most dramatic runs in U.S. telecom this year. On Friday, December 5, EchoStar stock closed around $82 per share, up roughly 10% on the day, after trading as high…
Broadcom (AVGO) Stock in December 2025: AI Chip Boom, VMware Cloud Push and What to Expect From Q4 Earnings

Broadcom (AVGO) Stock in December 2025: AI Chip Boom, VMware Cloud Push and What to Expect From Q4 Earnings

Broadcom (AVGO) Stock in December 2025: AI Chip Boom, VMware Cloud Push and What to Expect From Q4 Earnings Broadcom Inc. (NASDAQ: AVGO) heads into its fiscal fourth‑quarter earnings report on Thursday, December 11, 2025, with its share price hovering near record territory and expectations for artificial intelligence (AI) revenue set sky‑high. As of Friday’s close, Broadcom stock traded around…
Cemtrex (CETX) Stock Update for December 6, 2025: Price Action, Reverse Split, Aerospace Pivot and 2026 Outlook

Cemtrex (CETX) Stock Update for December 6, 2025: Price Action, Reverse Split, Aerospace Pivot and 2026 Outlook

As of December 6, 2025, Cemtrex, Inc. (NASDAQ: CETX) sits at the intersection of aggressive strategic expansion and extreme share-price volatility. After a series of reverse stock splits, equity raises, and new acquisition plans, the micro‑cap security and industrial services company is attempting to reinvent itself with a new aerospace and defense segment—while technical and algorithmic models remain broadly bearish…
Moderna (MRNA) Stock: French Study Sparks Rally After FDA Shock – Latest News, Analyst Forecasts and 2026 Outlook

Moderna (MRNA) Stock: French Study Sparks Rally After FDA Shock – Latest News, Analyst Forecasts and 2026 Outlook

Updated: December 6, 2025 Moderna, Inc. (NASDAQ: MRNA) has just had one of its most dramatic weeks of 2025. Shares plunged early in the week after news that the U.S. Food and Drug Administration (FDA) may tighten vaccine approval standards, then rebounded sharply on Friday after a massive French real‑world study reaffirmed the safety and effectiveness of its COVID‑19 vaccine.…
6 December 2025
Moderna (MRNA) Stock Jumps on New Vaccine Safety Data – Latest News, Forecast & Analysis for December 5, 2025

Moderna (MRNA) Stock Jumps on New Vaccine Safety Data – Latest News, Forecast & Analysis for December 5, 2025

Moderna, Inc. (NASDAQ: MRNA) closed today as one of the more talked‑about healthcare names on Wall Street, with the stock rebounding sharply after a bruising year of falling COVID-19 vaccine sales, pipeline setbacks, and rising regulatory risk. Today’s move comes as investors digest a huge, real‑world French study supporting the long‑term safety and effectiveness of mRNA COVID vaccines, fresh details…
Netflix Stock (NFLX) on December 5, 2025: Warner Bros. Megadeal, 10-for‑1 Split and Fresh Analyst Forecasts

Netflix Stock (NFLX) on December 5, 2025: Warner Bros. Megadeal, 10-for‑1 Split and Fresh Analyst Forecasts

Netflix stock is having one of its most consequential trading days in years. On December 5, 2025, shares of Netflix, Inc. (NASDAQ: NFLX) traded around $100–101, down roughly 2.8% on very heavy volume after the company confirmed an $82.7 billion deal to acquire Warner Bros. and its streaming assets. StockAnalysis At the same time, the stock is still digesting a…
Philip Morris International (PM) Stock: Price Today, Ferrari Deal, 2025 EPS Guidance and Analyst Forecasts (December 5, 2025)

Philip Morris International (PM) Stock: Price Today, Ferrari Deal, 2025 EPS Guidance and Analyst Forecasts (December 5, 2025)

Philip Morris International Inc. (NYSE: PM) is ending the first week of December on a cautious note. After a sharp pullback on Thursday, the stock is trading around $148 per share on December 5, 2025, roughly 20% below its 52‑week high of $186.69 but still up strongly year‑to‑date. MarketWatch At the same time, the company has just reaffirmed double‑digit earnings…
Trilogy Metals (TMQ) Stock: U.S. Stake, Ambler Road and 2026 Outlook

Trilogy Metals (TMQ) Stock: U.S. Stake, Ambler Road and 2026 Outlook

As of December 5, 2025 Trilogy Metals Inc. (NYSE American: TMQ; TSX: TMQ) has gone from thinly traded copper explorer to one of the most closely watched critical‑minerals plays in North America. A proposed 211‑mile road into Alaska’s Ambler Mining District, a planned 10% equity stake from the U.S. government, and an aggressive capital‑raising toolkit have transformed both the story…
1 53 54 55 56 57 90

Stock Market Today

  • Mader Group Shares Surge 11.3% on Broker Upgrade and New 5-Year Strategy
    January 22, 2026, 12:16 PM EST. Mader Group (ASX:MAD) shares rose 11.3% following a broker upgrade from Bell Potter and the unveiling of a new 5-year strategy. The upgrade emphasized Mader's strong positioning in Australia and North America and its expanding global maintenance services footprint. Market focus has shifted to the company's upcoming strategy update, viewed as a key catalyst. Despite positive sentiment, concerns remain about the stock's full earnings multiple and governance issues, including limited board independence. Analysts' fair value estimates vary widely between A$6.48 and A$9.15, reflecting differing views on growth and risk. Investors should weigh these factors carefully amid expectations for sustained revenue and profit growth.
Go toTop